Sign up to save your podcasts
Or
Share 100% Bullish: Simvastatin in MS, Communicating Risk
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
100% Bullish: Simvastatin in MS, Communicating Risk
This week: Simvastatin in Secondary Progressive Multiple Sclerosis and Communicating With Patients About Risk Rebecca and Amol want you to: 1. Recognize that simvastatin reduces the rate of whole brain atrophy in secondary progressive MS, which may be a promising new use for statins. 2. Understand that effective strategies to communicate risk include: Using visual aids, speaking ...
The post 100% Bullish: Simvastatin in MS, Communicating Risk appeared first on Healthy Debate.
View all episodes
By Dr. John Fralick and Dr. Michael Fralick
5
1212 ratings
This week: Simvastatin in Secondary Progressive Multiple Sclerosis and Communicating With Patients About Risk Rebecca and Amol want you to: 1. Recognize that simvastatin reduces the rate of whole brain atrophy in secondary progressive MS, which may be a promising new use for statins. 2. Understand that effective strategies to communicate risk include: Using visual aids, speaking ...
The post 100% Bullish: Simvastatin in MS, Communicating Risk appeared first on Healthy Debate.
More shows like The Rounds Table
View all
Hidden Brain
43,696 Listeners
NEJM This Week
321 Listeners
Emergency Medicine Cases
544 Listeners
JAMA Clinical Reviews
501 Listeners
This Week in Cardiology
886 Listeners
Under the Influence with Terry O'Reilly
789 Listeners
The Curbsiders Internal Medicine Podcast
3,364 Listeners
The Daily
112,843 Listeners
Up First from NPR
56,894 Listeners
Core IM | Internal Medicine Podcast
1,141 Listeners
The Intern At Work: Internal Medicine
65 Listeners
The Peter Attia Drive
8,629 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Cardionerds: A Cardiology Podcast
424 Listeners